Srinivasa Bhattachar, Vineet Malhotra, Uday Yanamandra, Surinderpal Singh et al.
Introduction: Acetazolamide is recommended for the prevention of acute mountain sickness (AMS); however, its use is limited in some areas because of side effects. Previous studies report ibuprofen to be similar to or slightly inferior to acetazolamide. This randomized, triple-blinded, parallel-group...
Nayana P. Nair, Samarasimha Reddy N, Sidhartha Giri, Tintu Varghese et al.
In 2016, India introduced Rotavac (G9P[11]), an indigenous oral rotavirus vaccine administered at 6, 10 and 14 weeks of age through the Universal Immunization Program. Evaluating its effectiveness under routine programmatic conditions is critical, given the variable performance of rotavirus vaccines...
Priya Ranganathan, Manju Sengar, Girish Chinnaswamy, Gaurav Agrawal et al.
Background: The COVID-19 pandemic has disrupted healthcare systems leading to concerns about its impact on non-COVID disease conditions. The diagnosis and management of cancer is time-sensitive and is likely to be substantially affected by these disruptions. We conducted a study to examine the impac...
GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study, Vinay Nangia, Prof Jost B Jonas et al.
PURPOSE: To estimate the prevalence of vision loss for 2020 in South and Central Asia and analyze trends since 1990. METHODS: In a systematic literature review, we estimated the prevalence of blindness, visual impairment (VI) and presbyopia-related VI in 1990,2000,2010, and 2020. RESULTS: The study ...